TheGlobal ProteinAssays Market, by Product Type (Reagents and Kits, Instruments), byTechnology Type (Absorbance-based Protein Assays, Colorimetric Protein Assays,Fluorescence-based Protein Assays), by Assay Type (Dye Binding Assays,Copper-Ion based Assays, Test Strip based Assays and Other Protein Assays) andby End User (Pharmaceutical and Biotechnology Companies, Clinical Laboratories,Hospitals and Academic Research Institutes) was valued at US$ 1,503.7 millionin 2016 and is projected to exhibit a CAGR of 7.6% over the forecast period(2017–2025).
Proteinquantification is a process in protein extraction in biochemistry and molecularbiology labs that involves protein extraction, analysis, or labeling.Quantification of protein is required for protein sample and analysis byelectrophoresis or chromatography or any other immunochemical techniques.Commonly used protein assays are Bradford, Lowry, BCA, and UV spectroscopicprotein assays. In April 2017, Millipore Sigma launched a new Single MoleculeCounting Platform, SMCxPROTM, which is based on the principle of immunoassayand it enables precise and sensitive detection over conventional methods.
Increasinginvestments of pharmaceutical companies in protein assays is leading todevelopment of various drugs. Protein assays initiatives have led to newdiscoveries and development of treatments tailored for specific characteristicssuch as genetic makeup or genetic profile of an individual tumor that helps tooffer relatively better and effective treatment methods. In 2015, According toa publication by Pharmaceuticals Research and Manufacturers of America (PhRMA)— a trade group representing companies in the pharmaceutical industry in theU.S.— the member organizations (pharmaceutical companies) of PhRMA investedaround US$ 58.8 billion on R&D, accounting for the largest of all thebiopharmaceutical R&D spending in the U.S, in 2015.
* The sample copy includes: Report Summary, Table ofContents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copyof this report: https://www.coherentmarketinsights.com/insight/request-sample/1087
Browse29 Market Data Tables and 33 Figures spread through 180 Pages and in-depth TOCon " Protein Assays Market, by Product Type (Reagents and Kits,Instruments), by Technology Type (Absorbance based Protein Assays, ColorimetricProtein Assays, Fluorescence based Protein Assays), by Assay Type (Dye BindingAssays, Copper-Ion based Assays, Test Strip based Assays and Other ProteinAssays), by End User (Pharmaceutical and Biotechnology Companies, ClinicalLaboratories, Hospitals and Academic Research Institutes) and by Region -Global Forecast to 2025"
AsiaPacific market is expected to witness highest growth in the global proteinassays market over the forecast period, owing to rising application of proteincontent determination in pharmacy and biotechnology. Increasing private-publicpartnership for genetic analysis has aided in the market growth. Risingbiotechnology and life sciences sector in this region, as well as increasingfocus on research and development by the top market players, is another factorfor growth of the market. For instance, in January, 2016, Thermo FisherScientific Inc. acquired Affymetrix to strengthen its position in biosciencesand genetic analysis as well as extend geographic reach of Affymetrix’sproducts by leveraging Thermo Fisher’s market presence and infrastructure inAsia Pacific, particularly China. Various new biomarker identification systems and emerging new uses forprotein assays provided opportunities to the players in the global proteinassay market. For instance, in June 2017, Gyros Protein Technologies ABlaunched a new version of its anti-drug antibody (ADA) solution for the immunogenicitysegment. Gyrolab ADA solution enables to automatically run drug-tolerant ADAassays in a time efficient way reducing hands-on time, using small volumes ofpatient samples and reagents, and reducing run-times. Manufacturers are likelyto focus on launching systems, which are expected to help understand proteinstructures and functions, with tools to characterize post-translationalmodifications, localization, and expression control including epigeneticmechanisms. In June 2015, Thermo Fisher Scientific Inc. introduced OrbitrapFusion Lumos Tribrid mass spectrometer and in 2017, it launched IntegratedUltraviolet Photo separation (UVPD) that enables specialists to performsubstantial and little atom structure assurance on a Lorentz focus (LC) time scale;and new advanced peak determination (APD) calculation that is intended toenhance execution of most proteomic work processes with high peptide andprotein ID rates.
Browse Research Report: https://www.coherentmarketinsights.com/market-insight/protein-assays-market-1087
KeyTakeaways of the Protein Assays Market:
Theglobal protein assays market is expected to exhibit a CAGR of 7.6% over theforecast period (2017–2025). This is attributed to increasing collaborationsamong pharmaceutical companies, academic researchers, regulators, andgovernment organizations across various regions.
Amongproduct type, reagents and kits segment is expected to account for the largestshare in the global protein assay market over the forecast period. This isattributed to quick and ready-to-use modifications and the requirement ofrepeat purchase of reagents.
Amongtechnology types, absorbance-based segment is expected to be largestcontributor in terms of revenue to the global market over the forecast period,and this is primarily attributed to expanding effectiveness and accuracy ofabsorbance-based proteins
Someof the major players involved in global protein assays market are Thermo FisherScientific Inc., GE Healthcare, Merck KGaA, Bio-Rad Laboratories, Inc., Lonza,Abcam plc, PerkinElmer Inc., Bio-Techne, BioVision Inc., Cell SignalingTechnology, Inc., and Geno Technology Inc.
Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/1087
AboutCoherent Market Insights:
CoherentMarket Insights is a prominent market research and consulting firm offeringaction-ready syndicated research reports, custom market analysis, consultingservices, and competitive analysis through various recommendations related toemerging market trends, technologies, and potential absolute dollaropportunity.
ContactUs:
mailto:sales@coherentmarketinsights.com
U.S.Office:
Name: Mr. Shah
CoherentMarket Insights 1001 4th Ave,
# 3200Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN: +050-5539-1737
